Author Archive

AvantGen awarded contract from NIH to expedite the commercialization of its AccuRate COVID-19 SelfCheck OTC test

March 9, 2022

AvantGen, a San Diego based biotechnology company with a superior yeast display technology for facile antibody discovery and optimization, has entered the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program to expedite the commercialization of its sensitive AccuRateTM COVID-19 SelfCheck Over-the-Counter (OTC) test. Applying their robust antibody discovery platform, AvantGen identified […]

Read more »

Adcentrx and AvantGen Enter a New Partnership with a Three-year, Multi-target Collaboration to Discover Antibodies for Novel Antibody-drug Conjugates

February 14, 2022

SAN DIEGO, Feb. 14, 2022 /PRNewswire/ — Adcentrx Therapeutics (“Adcentrx”), a biotechnology company focused on accelerating breakthroughs in antibody drug conjugate (“ADC”) therapeutic development, and AvantGen, a leader in the use of yeast display technology for human antibody discovery and optimization, announced today a three-year, multi-target partnership for the discovery of antibodies to be developed into novel ADC […]

Read more »